a feeling of her throat swelling; palpitation; shortness of breath; burning sensation; chest pain; sore throat; hoarseness of voice; post nasal drip; This spontaneous case was reported by a physician and describes the occurrence of PHARYNGEAL SWELLING (a feeling of her throat swelling), PALPITATIONS (palpitation), DYSPNOEA (shortness of breath), BURNING SENSATION (burning sensation) and CHEST PAIN (chest pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Trigeminal neuralgia. Concurrent medical conditions included Drug intolerance (intolerance of multiple medications), Hypertension, Hyperlipidemia since 21-Jul-2015, Gastritis since 12-Apr-2020, GERD since 31-Mar-2020 and Obstructive sleep apnea syndrome.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (a feeling of her throat swelling), PALPITATIONS (palpitation), DYSPNOEA (shortness of breath), BURNING SENSATION (burning sensation), CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), DYSPHONIA (hoarseness of voice) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form; ALBUTEROL [SALBUTAMOL] at a dose of 1 dosage form; COLCHICINE for Pericarditis, at a dose of 1 dosage form; PREDNISONE for Adverse event, at an unspecified dose and frequency and OSELTAMIVIR PHOSPHATE (TAMIFLU) for Pericarditis, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (a feeling of her throat swelling), PALPITATIONS (palpitation), DYSPNOEA (shortness of breath), BURNING SENSATION (burning sensation), CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), DYSPHONIA (hoarseness of voice) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Blood pressure measurement: 149/62 (High) 149/62. On 17-Feb-2021, Chest X-ray: normal (normal) normal. On 17-Feb-2021, Electrocardiogram: abnormal (abnormal) showed sinus bradycardia, no ST changes.. On 17-Feb-2021, Heart rate: 59 (Inconclusive) 59. On 24-Feb-2021, Blood pressure measurement: 130/58 (High) 130/58. On 24-Feb-2021, Heart rate: 53 (Inconclusive) 53. On 03-Mar-2021, Blood pressure measurement: 133/54 (High) 133/54. On 03-Mar-2021, Heart rate: 61 (Inconclusive) 61. In March 2021, Electrocardiogram: normal (normal) normal. In March 2021, Oxygen saturation: 98 (normal) 98. In March 2021, Physical examination: normal (normal) normal.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-130137, MOD-2021-130137 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: additional information received on 13-MAY-2021 , patient demographics updated, lab tests added, medical histories added, treatment drugs and new non serious events updated